Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14462882 | 0.80 | PKM (0.41) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL16604342 | 0.80 | PKM (0.43) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL14725133 | 0.80 | PKM (0.43) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL9194294 | 0.78 | PKM (0.39) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL12563055 | 0.77 | — | — | |
| SCHEMBL12563075 | 0.76 | CYP4F2 (0.36) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL847248 | 0.75 | ALDH1A1 (0.48) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL16589248 | 0.75 | MMP8 (0.38) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL1537694 | 0.74 | PKM (0.50) | PKMKDM4EALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL18050454 | 0.73 | ALDH1A1 (0.52) | PKMKDM4EALDH1A1CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8470891-B2 | Biodegradable block polymers for drug delivery, and methods related thereto | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2013-06-25 | — | — | US | disclosed |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | SAMM50, ADRM1, UFM1 | PKM 77/4885KDM4E 2840/4885ALDH1A1 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.